Myelodysplastic Syndrome with Excess Blasts-1
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome with Excess Blasts-1.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Ikervis for DED Due to GVHD Post Allo-HSCT [Phase 4]
Clinical trial update for Ikervis in DED due to GVHD after allogeneic stem cell transplant (Phase 4) with unknown status.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia [Phase 2]
A Phase 2 trial investigates adding lenalidomide or vorinostat to azacitidine in higher-risk myelodysplastic syndromes or chronic myelomonoc…